论文部分内容阅读
目的:观察肝复丸联合西药治疗早期肝硬化的临床效果。方法:将130例早期肝硬化患者随机分为治疗组和对照组各65例。对照组患者采用常规保肝、抗炎、抗病毒及对症治疗,治疗组在对照组治疗基础上加用肝复丸治疗,两组均以3个月为1个疗程。比较两组患者治疗后的临床症状以及肝功能指标改善情况。结果:治疗组在腹胀、肝区不适、厌食乏力、腹水等症状改善方面与对照组比较,差异均有统计学意义(P<0.01);治疗组肝功能指标谷丙转氨酶(ALT)、谷草转氨酶(AST)、血清白蛋白及血清总胆素改善程度与对照组比较,差异均有统计学意义(P<0.01)。结论:肝复丸联合西药治疗早期肝硬化有较好疗效。
Objective: To observe the clinical effect of Ganfusu pill combined with Western medicine in treating early liver cirrhosis. Methods: 130 cases of early cirrhosis were randomly divided into treatment group and control group of 65 cases. Patients in the control group were treated with conventional hepatoprotective, anti-inflammatory, antiviral and symptomatic treatment. The treatment group was treated with Ganfuxu pills on the basis of the control group. Both groups were given a course of 3 months. The clinical symptoms and the improvement of liver function were compared between the two groups. Results: Compared with the control group, the treatment group had statistically significant differences (P <0.01) in the aspects of abdominal distension, liver discomfort, anorexia nervosa, ascites and other symptoms. The ALT, AST, (AST), serum albumin and serum total cholesterol in the control group, the differences were statistically significant (P <0.01). Conclusion: Liver Fushan combined with Western medicine in the treatment of early cirrhosis have a good effect.